BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3133532)

  • 1. Effect of nigrostriatal dopamine depletion on the post-training, memory-improving action of amphetamine.
    White NM
    Life Sci; 1988; 43(1):7-12. PubMed ID: 3133532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of striatal neurons by dexamphetamine is antagonized by degeneration of striatal dopaminergic terminals.
    Warenycia MW; McKenzie GM
    J Neural Transm; 1987; 70(3-4):217-32. PubMed ID: 3119772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Origin of various enzymes released from the substantia nigra and caudate nucleus: effects of 6-hydroxydopamine lesions of the nigro-striatal pathway.
    Greenfield SA; Grünewald RA; Foley P; Shaw SG
    J Comp Neurol; 1983 Feb; 214(1):87-92. PubMed ID: 6404955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ascorbate blocks amphetamine-induced turning behavior in rats with unilateral nigro-striatal lesions.
    Tolbert LC; Thomas TN; Middaugh LD; Zemp JW
    Brain Res Bull; 1979; 4(1):43-8. PubMed ID: 572739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A two-population model of rat rotational behavior: effects of unilateral nigrostriatal 6-hydroxydopamine on striatal neurochemistry and amphetamine-induced rotation.
    Shapiro RM; Glick SD; Camarota NA
    Brain Res; 1987 Nov; 426(2):323-31. PubMed ID: 2446711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems.
    Koob GF; Simon H; Herman JP; Le Moal M
    Brain Res; 1984 Jun; 303(2):319-29. PubMed ID: 6430466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of endogenously synthesized catechols from the caudate nucleus by stimulation of the nigro-striatal pathway and by the administration of d-amphetamine.
    Chiueh CC; Moore KE
    Brain Res; 1973 Feb; 50(1):221-5. PubMed ID: 4690549
    [No Abstract]   [Full Text] [Related]  

  • 8. Non-dopaminergic nigrostriatal pathway.
    Guyenet PG; Crane JK
    Brain Res; 1981 Jun; 213(2):291-305. PubMed ID: 7248760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unilateral 6-hydroxydopamine lesions of dopamine neurons produce bilateral self-stimulation deficits.
    Carey RJ
    Behav Brain Res; 1982 Oct; 6(2):101-14. PubMed ID: 6814462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic grafts in the striatum reduce D1 but not D2 receptor-mediated rotation in 6-OHDA-lesioned rats.
    Robertson GS; Fine A; Robertson HA
    Brain Res; 1991 Jan; 539(2):304-11. PubMed ID: 1675908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that [3H]dopamine is taken up and released from nondopaminergic nerve terminals in the rat substantia nigra in vitro.
    Kelly E; Jenner P; Marsden CD
    J Neurochem; 1985 Jul; 45(1):137-44. PubMed ID: 3923157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional validation of projection topography in the nigrostriatal dopamine system.
    Redgrave P; Mitchell I
    Neuroscience; 1982 Apr; 7(4):885-94. PubMed ID: 6808415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotoxic action of 6-hydroxydopamine on the nigrostriatal dopaminergic pathway in rats sensitized with D-amphetamine.
    Nowak P; Kostrzewa RM; Kwieciński A; Bortel A; Labus Ł; Brus R
    J Physiol Pharmacol; 2005 Jun; 56(2):325-33. PubMed ID: 15985712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphetamine anorexia: the effect of radio-frequency lesions and 6-OHDA injections into dopaminergic nigro-striatal bundle in cats.
    Konopacki J
    Pol J Pharmacol Pharm; 1983; 35(6):497-502. PubMed ID: 6429650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injection of 6-hydroxydopamine into the substantia nigra of the rat. II. Diffusion and specificity.
    Agid Y; Javoy F; Glowinski J; Bouvet D; Sotelo C
    Brain Res; 1973 Aug; 58(2):291-301. PubMed ID: 4756131
    [No Abstract]   [Full Text] [Related]  

  • 17. Circling in normoxic or hypoxic rats with unilateral 6-OHDA nigrostriatal lesion. Part 2. Effects of d-amphetamine.
    Saligaut C; Daoust M; Moore N; Boismare F
    Methods Find Exp Clin Pharmacol; 1987 May; 9(5):285-9. PubMed ID: 3112478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway.
    Costall B; Naylor RJ; Pycock C
    Eur J Pharmacol; 1976 Feb; 35(2):276-83. PubMed ID: 942921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine depletion protects striatal neurons from ischemia-induced cell death.
    Clemens JA; Phebus LA
    Life Sci; 1988; 42(6):707-13. PubMed ID: 3123836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-Amphetamine reduces striatal substance P concentrations by presynaptic release of dopamine.
    Pettibone DJ; Wurtman RJ
    Brain Res; 1980 Mar; 186(2):409-19. PubMed ID: 6153555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.